SPC-VISMODEGIB DIN 02571978
Health Canada record
| Active ingredient(s) | VISMODEGIB 150 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01XJ01 VISMODEGIB |
| Original market date | |
| Current status date | 28-Sep-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sun Pharma Canada Inc. — licence 3-002572, currently licensed, last inspection rating C (2026-06-15).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing VISMODEGIB
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02409267 | ERIVEDGE | HOFFMANN-LA ROCHE LIMITED | Capsule | VISMODEGIB 150 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 38362 | 2026-09-28 | Abbreviated New Drug Submission (ANDS) |
International API supply for VISMODEGIB
7 active FDA Drug Master Files.
Request a quote for SPC-VISMODEGIB